Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease. But the ...
UK start-up Complement Therapeutics has raised an impressive €72 million ($79 million) in first-round financing that will be used to take a gene therapy for sight-robbing disease geographic atrophy ...
LibreOffice Writer est un logiciel de traitement de texte polyvalent et gratuit, capable de rivaliser avec ses homologues payants en termes de fonctionnalités et de performance. Il est un choix idéal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback